Fosun International sells 9,897,000 Gland Pharma shares for INR 27.996 billion

PUBT · 1d ago
Fosun International sells 9,897,000 Gland Pharma shares for INR 27.996 billion
  • Fosun International’s Fosun Pharma Singapore sold 9,897,000 Gland Pharma shares in India on Sept. 4, 2026.
  • Stake fell to 45.76% from 51.76%; Gland Pharma remains a Fosun Pharma subsidiary.
  • Gross proceeds totaled INR 27.996 billion, including transaction costs; average price INR 2,828.78 per share.
  • Proceeds earmarked for Fosun Pharma R&D, share repurchases, borrowing repayments.
  • Transaction not expected to generate a gain or loss because Gland Pharma will remain consolidated.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fosun International Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260906-12322358), on September 06, 2026, and is solely responsible for the information contained therein.